> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection Extension for Product Interruption Notices
- URL: https://www.fdaweb.com/info-collection-extension-for-product-interruption-notices/
- Published: 2018-07-26T12:00:00.000Z
- Updated: 2026-09-15T00:21:52.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141975

*Federal Register* notice: FDA has submitted to OMB an information collection extension for “Permanent Discontinuation or Interruption in Manufacturing of Certain Drug and Biological Products — 21 CFR 310.306, 314.81(b)(3)(iii), and 600.82” (OMB Control Number 0910-0759). FDA regulations require manufacturers to provide notice of a permanent discontinuance of the manufacture of the drug or biological product, or an interruption in manufacturing, that is likely to lead to a meaningful disruption in its supply. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-07-26/pdf/2018-15948.pdf?ref=fdaweb.com).